Hussain M, et al. J Clin Oncol. 2018;36 (suppl 6S; abstr 3).
Three-year Safety of Radium-223 in Patients with mCRPC and Symptomatic Bone Metastases
jul 2017 | Uro-oncologie
feb 2024 | Longoncologie
dec 2023 | Uro-oncologie
dec 2022 | Maag-darm-leveroncologie
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie
sep 2024
jul 2024
jun 2024
mrt 2024